Current oral GLP-1 medications often require patients to take them at specific points of the day, or to wait certain amounts of time before eating after taking the medication
Consult with a healthcare provider to see which revolutionary treatment is the most suitable for you
Neither the Summary of Product Characteristics (SmPC) for Rybelsus nor major drug interaction databases identify ibuprofen as a contraindicated or significantly interacting medication
At the time of writing, this is a two-step process
Clinical trials show 812% loss at standard doses is common, but individual results range from 215% depending on genetics, baseline weight, dose, and lifestyle
From the first consultation to long-term check-ins, every stage is simplified